Table 6 Comparison of total physical doses totarget volume calculated using AAA and AXB for peripheral and centrally-located tumor patients
Tumor location | Target (dose metric) | Median dose (range) in Gy | P-values | |
|---|---|---|---|---|
| Â | Â | AAA | AXB | Â |
peripheral | ITV (mean) | 63.7 (62.3, 67.9) | 63.9 (60.5, 68.1) | 0.86 |
| Â | PTV (D95%) | 60.0 (normalization) | 58.3 (53.5,60.3) | 4.66E-07 |
| Â | PTV (mean) | 62.9 (61.7, 65.0) | 62.2 (60.5, 64.5) | 0.04 |
| Â | PTV (max) | 66.0 (63.7, 73.2) | 67.0 (64.1, 75.5) | 0.19 |
| Â | PTV (min) | 55.2 (51.2, 57.1) | 51.3 (37.6, 56.1) | 1.19E-05 |
Central | ITV (mean) | 64.7 (63.6, 73.1) | 64.1 (61.1, 69.3) | 0.31 |
| Â | PTV (D95%) | 60.0 (normalization) | 59.0 (55.6, 59.4) | 1.00E-4 |
| Â | PTV (mean) | 63.5 (62.8, 67.2) | 62.6 (61.0, 66.0) | 0.04 |
| Â | PTV (max) | 66.9 (64.8, 86.9) | 67.5 (63.9, 84.4) | 0.83 |
| Â | PTV (min) | 53.1 (45.1, 57.0) | 50.4 (42.3, 53.6) | 0.06 |